Substance misuse in patients with schizophrenia: a primary care guide.
Smoking presents a substantial health and economic burden to people with schizophrenia. Comorbid use of other substances is common, under-recognised, and associated with a number of serious adverse consequences, such as psychotic relapse and poorer social outcomes. All patients with schizophrenia need to be screened for substance misuse. Effective interventions involve integrated, modified pharmacological and psychosocial strategies.
Orygen Research Centre, Cognitive Neuropsychiatry Research and Academic Unit, University of Melbourne, VIC. dan.lubman@mh.org.au
Dan I
DI
Lubman
Suresh
S
Sundram
D001315:Australia; D003156:Community Mental Health Services; D017281:Cost of Illness; D017831:Diagnosis, Dual (Psychiatry); D006801:Humans; D008403:Mass Screening; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000592:standards; D012559:Schizophrenia; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000628:therapy*